Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2018
(3)
2017
(4)
2014
(1)
2011
(1)
Decision
Transfer
(7)
Cancellation
(2)
Complainant
Sanofi
(8)
Genzyme Corporation
(2)
Sanofi-aventis
(1)
Respondent
Cimpress Schweiz GmbH
(3)
VistaPrint Technologies Ltd, VistaPrint Technologies Ltd
(2)
Marek Zdanowicz
(2)
VistaPrint Technologies Ltd
(1)
Contactprivacy.com / Domain Management
(1)
Panelist
Georges Nahitchevansky
(2)
Nayiri Boghossian
(1)
Mauricio Jalife Daher
(1)
Lynda M. Braun
(1)
J. Nelson Landry
(1)
Gareth Dickson
(1)
Dinant T. L. Oosterbaan
(1)
David J.A. Cairns
(1)
Complainant Country
France
(9)
Complainant Representative
Selarl Marchais De Candé
(3)
Selarl Marchais & Associés
(3)
Marchais
(3)
Respondent Country
Switzerland
(3)
Bermuda
(3)
South Africa
(2)
Canada
(1)
Respondent Reply
Yes
(3)
No
(6)
RDNH Status
No
(9)
Case Language
English
(9)
Case Particular
D
(9)
Number Of Domains
1
(8)
3
(1)
Domain Extension
com
(9)
Domain Extension Type
gTLD
(9)
Domain Length
6
(2)
7
(2)
9
(1)
13
(3)
14
(2)
19
(1)
Includes Hyphen
No
(9)
Includes Number
Yes
(1)
No
(8)
Includes Letter
Yes
(9)
Domain Registrar
Tucows Domains Inc.
(9)
9
cases found.
Case Particular: D
Complainant: Sanofi
Domain Extension: com
Includes Hyphen: No
Domain Registrar: Tucows Domains Inc.
Reset Search
sanofiinc.com
Transfer
WIPO D2018-1397
(Decision Date: Aug. 12, 2018)
san0figenzyme.com
Transfer
WIPO D2018-0296
(Decision Date: April 18, 2018)
sanofigemzymes.com
Transfer
WIPO D2018-0295
(Decision Date: April 18, 2018)
sanofipesteur.com
Transfer
WIPO D2017-1342
(Decision Date: Sept. 2, 2017)
saanofi.com
Transfer
WIPO D2017-0522
(Decision Date: May 26, 2017)
snaofi.com
Transfer
WIPO D2017-0095
(Decision Date: March 16, 2017)
saonfi.com
Transfer
WIPO D2016-2545
(Decision Date: Feb. 1, 2017)
sanofii.com, sanofipaasteur.com, sanofiusservicesinc.com
Cancellation
WIPO D2014-0842
(Decision Date: Aug. 21, 2014)
sanofigenzyme.com
Cancellation
WIPO D2011-0574
(Decision Date: June 9, 2011)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll